Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC).
Document Type
Article
Publication Date
5-25-2020
Publication Title
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Clinical Institute
Cancer
Department
Oncology
Department
Earle A. Chiles Research Institute
Recommended Citation
Sanchez, Katherine; Chang, Shu-Ching; Kim, Isaac; Martel, Maritza; Wu, Yaping; Redmond, William L.; Sun, Zhaoyu; Waddell, Dottie; Laxague, Deborah R.; Bernard, Brady; Shah, Monil; Urba, Walter; and Page, David B., "Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC)." (2020). Articles, Abstracts, and Reports. 3760.
https://digitalcommons.providence.org/publications/3760
